Merck & Company, Inc.
Pembelian

Long $MRK

208
- MRK is a quality compounder selling at a discount.

Year | 2025 | 2026 | 2027 | 2028
EPS | 8.90 | 9.72 | 10.65 | 10.38
EPS% | 18.36% | 9.21% | 9.54% | -2.52%


Conservative forward p/e should be 10

Fair Stock value:
EPS | 8.90 | 9.72 | 10.65 | 10.38
Price | 89 | 97 | 106 | 103

Positive Suprises or rotation into healthcare by fund manager would leead to forward p/e of 15

EPS | 8.90 | 9.72 | 10.65 | 10.38
Stock price | 133 | 145 | 159 | 155
Catatan
Bullish: Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda
Catatan
Let's go MRK
Catatan
MRK has entered my target range box
Catatan
Fair value for MRK in 2026 is $135-145

Pernyataan Penyangkalan

Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.